Transcutaneous Spinal Cord Stimulation in Hereditary Spastic Paraplegias
Objective: To assess transcutaneous spinal cord stimulation (tSCS) as a treatment for hereditary spastic paraplegias (HSPs). Background: Hereditary spastic paraplegias (HSPs) are genetic disorders characterized…IncobotulinumtoxinA for the Treatment of Lower Limb Spasticity in Children and Adolescents with Cerebral Palsy Evaluation of Lower Limb IncobotulinumtoxinA Efficacy (ELLIE)
Objective: To investigate the use of incobotulinumtoxinA in the treatment of lower limb spasticity in children and adolescents with cerebral palsy (CP). Background: Spasticity associated…Continuous subcutaneous foslevodopa/foscarbidopa infusion therapy leads to a sustained reduction in dyskinesias in Parkinson’s disease
Objective: To assess the longitudinal effect of continuous subcutaneous foslevodopa/foscarbidopa infusion therapy on dyskinesias as measured by the Unified Dyskinesia Rating Scale (UDysRS) total score…Characteristics of IncobotulinumtoxinA Treatment for Limb Spasticity in a Real-World Setting: Dosing and Muscles Injected
Objective: This study described incobotulinumtoxinA doses and muscles injected in a real-world setting for patients with limb spasticity (LS). Background: IncobotulinumtoxinA is approved to treat…Extracorporeal Shockwave Therapy (ESWT) for Neck Pain and Shoulder-Scapular Dyskinesis: An Objective Evaluation Study
Objective: The aim was to objectively evaluate the role of shoulder and scapular movement in neck pain and assess the efficacy of ESWT for treatment.…Identifying and Managing Spasticity in Neurological Shoulder Dysfunction
Objective: To understand this discrepancy between diagnosis and treatment of spasticity in neurological shoulder dysfunction, we formed an expert panel to establish consensus and provide…Effectiveness of abobotulinumtoxinA in adults with lower limb spasticity: Results from the AboLiSh real world observational study
Objective: Assess longitudinal goal attainment with repeated injections of abobotulinumtoxinA (aboBoNT-A) in the lower-limb over 16-months in a routine clinical setting. Background: While the efficacy…Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real world practice
Objective: Describe abobotulinumtoxinA (aboBoNT-A) dosing parameters for the most currently targeted muscles in the routine management of lower limb spasticity. Background: The efficacy and safety…Feasibility and Comprehensibility of the SMD Decision Tree for Early Recognition of Spasticity
Objective: The comprehensibility, feasibility, and appraisal of the Spastic Movement Disorders Decision Tree (SMD-DT) was assessed by qualitative analysis of study feedback collected from raters…Pathways for diagnosis and multimodal management, including botulinum neurotoxin therapy, in shoulder conditions following central lesions
Objective: To build on existing publications and give guidance for healthcare providers managing shoulder conditions following central lesions, including how to identify, diagnose, and treat…
- 1
- 2
- 3
- …
- 7
- Next Page »